How is the Pharmaceutical Supply Chain Evolving?
- Pharmaceutical companies are increasingly focused on personalized medicines—and they're facing new challenges as a result.
April 8, 2020
Pharma companies are increasingly focusing on specialty and precision medicines. TraceLink Digital Transformation Strategist Roddy Martin explains the implications of this monumental shift.
The pharmaceutical supply chain, the product supply system, has fundamentally changed. No longer is it protected by 85% margins and making millions of tablets for millions of patients. We’re now at the exciting stage of science and technology where we can actually make a therapy for a single patient.
The industry has a real challenge, and that is: Where we’ve built facilities to manufacture tablets for millions of patients, we now have to scale down and produce one therapy on a much smaller, more concise science-driven model.
This is where digital really comes into the picture and allows us to create operating models that are fundamentally different.
Return to: The Patient-Driven Supply Network